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Summary
The use of antimicrobials in human and veterinary
medicine has coincided with a rise in antimicrobial
resistance (AMR) in the food-borne pathogens
Campylobacter jejuni and Campylobacter coli.
Faecal contamination from the main reservoir hosts
(livestock, especially poultry) is the principal route of
human infection but little is known about the spread of
AMR among source and sink populations. In particular,
questions remain about how Campylobacter resistomes
interact between species and hosts, and the potential
role of sewage as a conduit for the spread of AMR. Here,
we investigate the genomic variation associated with
AMR in 168 C. jejuni and 92 C. coli strains isolated from
humans, livestock and urban effluents in Spain. AMR
was tested in vitro and isolate genomes were sequenced
and screened for putative AMR genes and alleles. Genes
associated with resistance to multiple drug classes were
observed in both species and were commonly present in
multidrug-resistant genomic islands (GIs), often located
on plasmids or mobile elements. In many cases, these
loci had alleles that were shared among C. jejuni and
C. coli consistent with horizontal transfer. Our results
suggest that specific antibiotic resistance genes have
spread among Campylobacter isolated from humans,
animals and the environment.
Introduction
Campylobacter is the leading cause of bacterial gastro-
enteritis in the European Union (EU) (Food and Authority,
2019). The most common pathogenic species, C. jejuni
and C. coli, were responsible for over 245,658 cases of
campylobacteriosis in the EU in 2016, surpassing disease
caused by Escherichia coli, Salmonella and Listeria (Food
and Authority, 2019). Campylobacter are a common con-
stituent of the gut microbiota of livestock including poultry,
ruminants and pigs (Sheppard et al., 2009a, 2011;
Sproston et al., 2011), and are also found in wild birds
(Sheppard et al., 2010a, 2010b; Griekspoor et al., 2013;
Cody et al., 2015; Atterby et al., 2018) and environmental
sources (Dingle et al., 2001; Colles et al., 2003; Sheppard
et al., 2009a). Human infection is typically associated with
the consumption of contaminated meat (Fravalo et al.,
2009; Hermans et al., 2012; Guyard-Nicodème et al.,
2013) and causes acute gastroenteritis and is self-limiting
after 3–5 days. In severe cases, antibiotic treatment may
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be required with fluoroquinolones and macrolides being
the drugs of choice (Acheson and Allos, 2001).
Despite the ban on the use of antibiotics as growth pro-
moters in animal feed in 2006 in the EU (Castanon,
2007), antimicrobial resistance (AMR) is still common
among bacteria of the gastrointestinal tract of farmed ani-
mals (Sheppard et al., 2009a,b; Sproston et al., 2011).
According to the latest European Centre for Disease Pre-
vention and Control (ECDC) report in 2017, C. jejuni and
C. coli isolates of clinical and animal origin showed high
levels of resistance to both ciprofloxacin and tetracycline
(Food and Authority, 2019). Furthermore, C. coli from clini-
cal and animal samples have displayed resistance to mac-
rolides including erythromycin and the aminoglycoside
streptomycin (Food and Authority, 2019). More worryingly,
there is an apparent trend towards multidrug resistance
(MDR), particularly among C. coli that regularly harbour
different AMR genes simultaneously within the genome of
a single isolate (Luangtongkum et al., 2009; Pascoe et al.,
2017; Food and Authority, 2019).
Mechanisms of resistance are well documented for
several drug classes including fluoroquinolones, tetracy-
clines, macrolides, aminoglycosides and β-lactams. Fluo-
roquinolone treatment was traditionally the first line of
defence against campylobacteriosis but resistance has
rapidly increased among strains (Sproston et al., 2018),
potentially because it requires only a single point muta-
tion in the genome (in the gyrA gene; Luo et al., 2003;
Gibreel, 2006; Payot et al., 2006; Luangtongkum et al.,
2009). This has led to a shift in treatment in favour of
erythromycin prescription (Nachamkin et al., 2000;
Gibreel, 2006), where resistance arises from specific
point mutations in 23S rRNA and develops relatively
slowly (Lapierre et al., 2016). However, in 2014, erythro-
mycin resistance was found in animal and clinical isolates
that carried an rRNA methylating enzyme, the ermB gene
(Qin et al., 2014; Wang et al., 2014). Two years later the
ermB gene was detected in C. coli isolates from turkeys
and chickens in Spain suggesting the mobilization of this
gene through horizontal gene transfer (HGT; Florez-
Cuadrado et al., 2016, 2018). Tetracycline resistance,
associated with the tetO gene encoding a ribosomal pro-
tection protein, has also been observed in Campylobac-
ter since 1987 (Sougakoff et al., 1987) and new enzymes
conferring resistance to aminoglycosides continue to be
discovered in Campylobacter (Lambert et al., 1985;
Iovine, 2013; Zhao et al., 2016). In addition to these
emerging trends, Campylobacter is known to have ‘natu-
ral’ resistance to β-lactams, such as penicillin, in large
part due to the ubiquity of the blaOXA-61 gene (Alfredson
and Korolik, 2005; Griggs et al., 2009). As a result of the
widespread resistance to multiple antibiotic classes, it is
no surprise that Campylobacter is a high priority patho-
gen on the recently published World Health Organization
(WHO) list of bacteria, for which new antibiotics are
urgently needed (WHO, 2017).
Many studies have highlighted the potential for trans-
mission of AMR bacteria between agricultural animals
and humans following extended use of antibiotics
(Boerlin and Reid-Smith, 2008; Huttner et al., 2013). How-
ever, controversy surrounding evidence for a direct link is
confounded by inconsistencies in interpreting what consti-
tutes the spread of resistance. Broadly, the spread of
AMR can be defined as a clonal transmission or gene pool
transmission. In clonal transmission, bacteria that have
acquired AMR in one niche are transmitted to another
where they retain resistance, such as in the survival of
resistant Campylobacter through the food production
chain to infect humans (Yahara et al., 2017). In gene pool
transmission, HGT facilitates the spread of resistance
genes between strains and species and the movement of
genes (rather than clones) into multiple genetic back-
grounds can be seen to spread AMR. Efforts to reduce
AMR and conserve the remaining efficacy of existing
drugs are focussed on the judicious use of antibiotics in
animals and humans. In this context, it is advantageous to
consider gene pool transmission as this is directly
influenced by the selection pressure to maintain resistance
in a given environment.
Campylobacter jejuni and C. coli can evolve rapidly,
accumulating large numbers of nucleotide substitutions
through mutation and recombination (Wilson et al., 2009;
Sheppard et al., 2010a, 2010b; Dearlove et al., 2016).
This can lead to de novo development of AMR through
point mutation as well as the acquisition of resistance ele-
ments from other bacteria through HGT (Yahara et al.,
2014, 2016). HGT has a major role in the mobilization of
AMR not only within bacterial species but even across
species boundaries. For example, the tetO gene that con-
fers resistance to tetracycline in Campylobacter (Taylor
et al., 1983; Batchelor, 2004) is believed to have origi-
nated via HGT from a Gram-positive bacterium, potentially
mediated by plasmid transfer (Taylor et al., 1983; Taylor,
1986; Batchelor, 2004). Interspecies genetic exchange
requires some degree of niche overlap or physical proxim-
ity of strains. However, while there is some understanding
of host niche segregation and clonal transmission of par-
ticular Campylobacter lineages (Sheppard et al., 2009a,
2010a, 2010b, 2014), there is limited quantitative informa-
tion about the transmission dynamics of AMR genes
between human, animal and environmental gene pools
(gene pool transmission) in this genus.
In this study, we sequence the genome of isolates from
a survey of AMR Campylobacter from multiple sources
in Spain. Multidrug resistance phenotypes are quantified
in vitro and compared to putative genomic determinants
identified from over 2,000 known AMR genes. The
co-localization of these genes within resistance islands is
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examined and the allelic variation is compared among
isolates from different sample sources. These analyses
provide a basis for considering the interaction of different
AMR gene pools and the potential source/sink contribu-
tion of livestock, humans and sewage effluents to the
Campylobacter resistome.
Results
Enhanced in vitro MDR in C. coli compared to C. jejuni
We collected 168 C. jejuni and 92 C. coli isolates of human,
animal and sewage origin (Supporting Information Table S1).
In vitro resistance to six antibiotics (ciprofloxacin, nalidixic
acid, tetracycline, erythromycin, streptomycin and gentami-
cin) of isolates of animal origin (Table 1, Supporting Informa-
tion Table S2) was compared to resistance profiles of isolates
of human and sewage origin (Table 1, Supporting Information
Table S2). All Campylobacter isolates that were resistant to
both ciprofloxacin and nalidixic acid were referred to as cipro-
floxacin resistant only because resistance is conferred by
SNPs in the same gene. The highest proportion of AMR was
to ciprofloxacin (146/163; 90.1% for C. jejuni and 86/91;
94.5% for C. coli) and tetracycline (149/163; 91.4% for
C. jejuni and 86/91; 94.5% forC. coli), followed by streptomy-
cin (24/163; 14.7% for C. jejuni and 58/91; 63.7% for C. coli),
erythromycin (4/162; 2.5% for C. jejuni and 23/91; 25.3% for
C. coli) and gentamicin (2/163; 1.2% for C. jejuni and 10/91;
11% for C. coli; Table 1, Supporting Information Table S2).
Higher prevalence of resistance was observed in C. coli
isolates to erythromycin, streptomycin and gentamicin
compared to C. jejuni (Fisher’s exact test; p < 0.001). Typi-
cally, an isolate is considered multidrug resistant when it is
resistant to at least three different classes of antibiotics
(European Centre for Disease Prevention and Control
[ECDC] & European Food Safety Authority [EFSA], 2015).
Based on this criterion, more C. coli isolates were MDR
(49/91; 53.8%) than C. jejuni (27/163; 16.6%; Table 2). All
C. coli isolates were resistant to at least one antibiotic.
(Table 2). Six (out of 163; 3.7%)C. jejuni isolates were sen-
sitive to all tested antibiotics. Most of the isolates tested
were resistant to both ciprofloxacin and tetracycline
(140/163 or 85.9% C. jejuni and 82/91 or 90.1% C. coli), of
which 52 C. coli isolates (57.1%) were also resistant to
streptomycin compared to 24 C. jejuni isolates (14.7%)
and nine C. coli isolates (9.9%) were also resistant to gen-
tamicin compared to two C. jejuni isolates (1.23%;
Table 2).
AMR isolates are distributed across highly structured
populations
High levels of AMR observed in laboratory assays could
indicate either an abundance of low diversity AMR clonesTa
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or proliferation of AMR in multiple lineages. To investi-
gate this, we analysed the population genomic structure
of AMR isolates. The core genome phylogeny revealed
that AMR isolates belonged to genome sequence clusters
consistent with existing multilocus sequence typing
(MLST) Sequence Type (ST) and clonal complex designa-
tions (Dingle et al., 2001; Miller, 2006; Fig. 1). Campylo-
bacter jejuni isolates of chicken and cattle origin were
mainly of host generalist (ST-21, ST-48, ST-206 and ST-
45) clonal complexes (Sheppard et al., 2010a, 2010b,
2014; Fig. 1A, Supporting Information Table S1). Cattle
isolates also belonged to ST-61 and ST-42 cattle associ-
ated clonal complexes, while human clinical isolates con-
tained isolates of these generalist and cattle associated
clonal complexes as well as additional generalist clonal
complexes (ST-22, ST-52) and chicken associated clonal
complexes (ST-257, ST-353, ST-354, ST-443, ST464, ST-
574 and ST-658; Fig. 1A, Supporting Information
Table S1). Campylobacter jejuni isolates from sewage
belonged to ST-362, a human associated complex and
generalist ST-22, ST-45 and ST-607 complexes (Fig. 1A,
Supporting Information Table S1). Multidrug resistant
C. jejuni isolates (27/167) were from generalist (ST-21,
ST-206, ST-45, ST-52) complexes, chicken associated
complexes (ST-354, ST-460 and ST-464) and cattle asso-
ciated complexes (ST-42 and ST-61; Fig. 1A, Supporting
Information Table S1). Campylobacter coli isolates repre-
sented 28 different STs, all of which belonged to the ST-
828 clonal complex. The most abundant STs were
825 and 827, constituting 20.7% and 17.4% of all C. coli
isolates (Fig. 1B, Supporting Information Table S1). The
proportion of C. coli isolates displaying MDR (60.9%) was
considerably higher than within C. jejuni (16.1%), nearly half
of which were isolated from sewage highlighting the poten-
tial importance of urban effluents as reservoirs of AMR
genes (Fig. 1B, Table 2). Clearly, diversity within this com-
plex is lower than in agricultural/clinical C. jejuni and one
might consider ST-828 complex to be a single clone. How-
ever, as illustrated (Fig. 1B), AMR is found in divergent line-
ages within the ST-828 complex and, importantly, is also
absent in some closely related strains. This pattern is incon-
sistent with the proliferation of a clone that acquired AMR
genes in a single ancestral acquisition event. Rather it sug-
gests horizontal transfer of AMR genes among
sublineages.
Campylobacter coli genomes harbour more AMR genes
than C. jejuni
The genome sequences of all Campylobacter isolates
were compared to 2,158, 2,280 and 4,324 known antibi-
otic resistance genes and alleles from the Comprehen-
sive Antibiotic Resistance Database (CARD; Cameron
and Gaynor, 2014), ResFinder (Zankari et al., 2012) and
the National Center for Biothechnology Information
(NCBI) databases respectively. The analysis revealed
the presence of 18 AMR genes including: cmeA, cmeB,
cmeC, blaOXA-61, tetO, ant-like A, ant-like B, ant(6)-Ia,
sat-1, sat-4, lnuC, ant(6)-Ib, aad9, aph(3)-IIIa, aph(2)-IIIa,
hpt, apmA and ermB (Fig. 2, Table 3; Trieu-Cuot et al.,
1985; Sougakoff et al., 1987; Achard et al., 2005;
Alfredson and Korolik, 2005; Griggs et al., 2009; Qin
et al., 2012; Toth et al., 2013; Cameron and Gaynor,
2014; Zhao et al., 2016; Florez-Cuadrado et al., 2016;
Olkkola et al., 2016; Yao et al., 2017). The cmeA, cmeB
and cmeC genes, associated with efflux pump function,
were present in all isolates. The blaOXA-61 and tetO
genes were common in resistant C. jejuni and C. coli iso-
lates (Fig. 2, Table 3). The genes ant-like A and ant-like
B have been described before as separate genes
Table 2. Multidrug resistant (in bold) and non-multidrug resistant Campylobacter isolates (n = 254) from humans, animals and sewage.
Campylobacter jejuni (n = 162) Campylobacter coli (n = 91)
Antibioticsa Animals Humans Sewage Animals Humans Sewage
CTESG – – – 4/11 (36.4%) 1/33 (3%) –
CTES – – – 5/11 (45.5%) 4/33 (12.1%) 5/47 (10.6)
Multiresistant CTSG – 2/115 (1.7%) – – 1/33 (3%) 3/47 (6.4%)
CTS 15/44 (34.1%) 7/115 (6.9%) – 1/11 (9.1%) 11/33 (33.3%) 17/47 (36.2%)
CTE 2/44 (4.5%) 1/115 (0/9%) – 1/11 (9.1%) 1/33 (3%) 2/47 (4.3%)
CT 16/44 (36.4%) 95/115 (82.6%) 2/4 (50%) – 12/33 (36.4%) 13/47 (27.7%)
CS – – – – – 1/47 (2.1%)
TE 1/44 (2.27%) – – – – –
Non-multiresistant TS 1/44 (2.27%) – – – 1/33 (3%) 4/47 (8.5%)
C 3/44 (6.8%) 1/115 (0.9%) 1/4 (25%) – 2/33 (6.1%) 2/47 (4.25%)
T 4/44 (11.4%) 5/115 (4.4%) – – – –
Non-resistant Sensitive 2/44 (4.5%) 4/115 (3.5%) – – – –
Total number of non-multidrug resistant 27/44 (61.36%) 101/115 (8.69%) 4/4 (100%) – 15/33 (45.45%) 27/47 (57.44%)
Total number of multidrug resistant 17/44 (38.63%) 10/115 (87.82%) – 11/11 (100%) 18/33 (54.54%) 20/47 (42.55%)
Total number of isolates 44 115 4 11 33 47
a. Antibiotics resistance to: C, ciprofloxacin; T, tetracycline; E, erythromycin; S, streptomycin; G, gentamicin.
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(Olkkola et al., 2016) and later revised as ant(6)-Ie
(Hormeño et al., 2018). To avoid the issues of gene duplica-
tion and gene paralogues they are considered as separate
genes in this study. The blaOXA-61 gene was significantly
more prevalent in C. jejuni (64.8%) than C. coli isolates
(51.1%; Fisher’s exact test; p < 0.05), while the ant-like
A gene was more prevalent in C. coli (40.22% of C. coli
and 1.19% of C. jejuni isolates, p < 0.001). The preva-
lence of the ant-like A gene was also significantly higher
in multidrug resistant isolates (33.7%) compared to non-
multidrug resistant isolates (6.7%; p < 0.001; Fig. 2,
Table 3), and associated (p < 0.005) with isolates from
humans (14.5%) and sewage (13.3%) compared to
those from animals (1.2%; p < 0.005; Fig. 2, Table 3). In
the case of non-multidrug resistant isolates, the
frequency difference of the ant-like A gene can probably
be attributed to the frequency of C. jejuni in human
infection samples compared to the abundance of C. coli
from sewage. Genes associated with aminoglycoside
resistance (ant(6)-Ia, sat-4, ant(6)-Ib, aad9, aph(3)-IIIa,
aph(2)-IIIa, hpt and apmA) were mainly found in C. coli
multidrug resistant isolates while sat-1 was detected in
only three C. jejuni strains from animals (Fig. 2,
Table 3). Genes ant(6)-Ia, sat-4, ant(6)-Ib and aph(3)-
IIIa were also found in C. jejuni isolates from animals
(Fig. 2, Table 3). The lnuC gene, conferring resistance
to lincosamides, was detected only in C. coli isolates
and the ermB gene, which is not commonly found in
Campylobacter, was detected in only one C. coli isolate
from a chicken (Fig. 2, Table 3). A strong positive
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correlation (p < 0.001) between resistance phenotypes and
genotypes was observed for tetracycline, streptomycin and
gentamicin that were tested in vitro (Supporting Information
Table S3). There was no correlation for erythromycin
because the associated AMR gene ermB was only
found in one isolate (Supporting Information Table S3).
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Concordance between putative resistance genotypes
and laboratory phenotypes was lower than in some pre-
vious studies (Tyson et al., 2015; McDermott et al.,
2016; Zhao et al., 2016). The main reason for this was
that our study principally focused on the differential
presence of AMR genes, to understand gene pool trans-
mission, rather than resistance conferred by point muta-
tion where it is more difficult to differentiate horizontal
acquisition from de novo mutation. Other incongruences
were observed between genotype prediction and labora-
tory phenotype. For example, not all isolates carrying
aminoglycoside resistance genes were phenotypically
resistant to streptomycin and gentamicin (Supporting
Information Table S3). This is consistent with previous
studies (Tyson et al., 2015; McDermott et al., 2016) and
is potentially associated with variation in gene expres-
sion levels or synergistic effects among different resis-
tance genes, warranting further study.
AMR genes are co-localized in the genome of multidrug
resistant isolates
AMR genes are often found in close proximity in the
genome. For example, aminoglycoside resistance genes
can form localized clusters within the genome (Werner
et al., 2003; Qin et al., 2012). The low numbers of apmA
and ermB genes identified, excluded them from formal
statistical comparison. Due to the high levels of resis-
tance to fluoroquinolones and tetracycline, the presence
of ant-like A, ant(6)-Ia, sat-4, ant(6)-Ib, aad9, aph(3)-IIIa,
aph(2)-IIIa, sat-1 and hpt genes, was by definition signifi-
cantly associated with MDR (Fisher’s exact test;
p < 0.001), because this was defined as resistance to
three or more antimicrobial classes (Table 3). There was
a slight increasing trend in the presence of ant-like A,
ant-like B, aad9, ant(6)-Ia, sat-4, ant(6)-Ib and aph(3)-IIIa
genes from 2010 to 2015 (Supporting Information
Fig. S1). Furthermore, the relative position of the 15 AMR
genes (in contiguous sequence assemblies) detected in
Campylobacter isolates revealed two types of genetic
associations in animal, human and sewage isolates. The
first was between ant(6)-Ia, sat-4 and aph(3)-IIIa genes,
which clustered together in three C. jejuni isolates (one
from chicken and two from cattle) and in eight C. coli iso-
lates (one from chicken, four from humans and three from
sewage; Fig. 3). This cluster has been previously
described with the three genes located on the same geno-
mic island in C. coli (Qin et al., 2012). The further addition
of the aph(2)-IIIa gene to this genomic island was
observed in two C. coli isolates from sewage (Fig. 3). The
second type of genetic association involved the presence
of tetO, aad9 and ant(6)-Ib genes. These genes clustered
together in six C. coli isolates (one from chicken, one from
pig, one from human and three from sewage) but also inTa
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Gene pool transmission of AMR 4603
one C. jejuni isolate from a human patient (Fig. 3). The
addition of the sat-1, hpt, apmA and ermB genes was also
observed in these two types of syntenic block (Fig. 3).
Evidence of gene pool transmission AMR genes
Evidence for HGT has been demonstrated for AMR genes
in various bacteria, including Campylobacter (Sheppard
et al., 2011, 2013; Wang et al., 2014; Sheppard and Maiden,
2015; Li et al., 2017), in some cases facilitated by mobile
genetic elements including plasmids and transposons
(Boerlin and Reid-Smith, 2008). We identified one plasmid
(pCFSAN032805; Accession: CP023546.1) in the genome
sequences of eight C. coli isolates (one from chicken, one
from a pig, three from humans and three from sewage;
Fig. 3). Furthermore, a C. jejuni plasmid (pCJ14980A;
Accession: CP017030.1) previously isolated from turkey fae-
ces (Florez-Cuadrado et al., 2017) was identified in a
C. jejuni isolate from cattle in our study (Fig. 3). A pTet plas-
mid (Accession: CP002030.1) was also detected in one
C. coli isolate of human origin (Fig. 3). A genomic region
that was carrying the gene cluster ant(6)-Ia, sat-4 and aph
(3)-IIIa was highly similar to an integrative conjugative
mobile element described in Erysipelothrix rhusiopathiae
(Accession: MG812141.1) isolated from a pig farm.
This region was also similar to sequences from other
bacteria like Clostridium difficile, Staphylococcus aureus,
S. pseudintermedius, Streptococcus suis and Enterococ-
cus faecium. These findings are consistent with the cir-
culation of genes, and more specifically alleles, not only
between host microbiome gene pools but also between
Campylobacter species. To investigate this further, we
compared allelic diversity for the 15 identified AMR
genes in C. jejuni and C. coli isolates.
The genes, blaOXA-61 and tetO, had the highest diversity
with 34 and 47 different alleles detected in C. jejuni and in
pCFSAN032805
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Fig. 3. Comparative genetic organization of AMR GIs in Campyloabcter. The presence of each AMR gene, highlighted in different colours, is
shown for representative C. jejuni and C. coli isolate genomes sampled from animals (A), humans (B) and sewage (C). The number of isolate
genomes containing each genomic island arrangement is indicated in the parenthesis. Grey shading identifies sequence that shares > 95%
nucleotide sequence identity. The name of the plasmid or mobile genetic element, associated with each genomic island, is indicated. [Color figure
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C. coli isolates respectively (Fig. 3, Supporting Information
Fig. S1). There were five blaOXA-61 alleles, two of which were
present in 16 and four C. jejuni and in 50 and five C. coli iso-
lates, respectively (Fig. 3, Supporting Information Fig. S1).
For the tetO gene, six alleles were present in more than five
isolates each, with the most common allele present in
19 C. jejuni and in 35 C. coli. For the aad9 and ant(6)-Ib
gene, both of which had five alleles, the most common allele
was present in both C. jejuni and C. coli isolates from multiple
sources (Fig. 3, Supporting Information Fig. S1, Table S2).
Finally, the sat-4 gene shared two out of the six alleles
between four C. jejuni and four C. coli isolates and the apmA
gene had one allele which was shared by a C. jejuni of
human origin and a C. coli isolated from a chicken (Fig. 3,
Supporting Information Fig. S1, Table S2). Remaining alleles
were detected exclusively in C. coli isolates.
Clonal descent is disrupted in AMR genes
The mean consistency index (CI) was significantly higher
(Mann–Whitney test; U = 3307, p = 0.0214) among AMR
genes (0.65581  0.3531) compared with 595 core genes
(0.4552  0.05799; Fig. 4A). This provides evidence that the
clonal mode of descent has been disrupted in AMR genes
consistent with HGT. Furthermore, there was a significant
decrease in the average allelic variation among AMR genes
compared to core genes (Mann–Whitney test; U = 1004,
p ≤ 0.0001; Fig. 4B). The average number of unique alleles
per isolate was 0.03436  0.05218 for the 15 AMR genes,
compared with 0.1169  0.05248 for 595 core genes. This
is consistent with HGT facilitating the movement of AMR
genes into multiple genetic backgrounds.
Among the AMR genes present in five or more isolates,
the blaOXA-61 and tetO alleles, associated with resistance to
β-lactams and tetracyclines respectively, were almost ubiq-
uitous among C. jejuni and in C. coli from different sources.
Two common blaOXA-61 alleles were present in both Cam-
pylobacter species in all different hosts and sewage with
other alleles shared only between human, chicken and
sewage isolates (Fig. 5). A single tetO allele was present in
the genomes of isolates from all different hosts and sewage
except for C. jejuni from humans and C. coli cattle (Fig. 5),
possibly due to low sample numbers (Supporting Informa-
tion Table S1). Another tetO allele was shared between
C. coli isolates from sewage and C. jejuni from chickens,
cattle and humans (Fig. 5). In addition to evidence of fre-
quent allele sharing between Campylobacter species from
multiple sources, there were also several species-specific
alleles found in isolates from multiple sources (Fig. 5). AMR
genes associated with aminoglycoside resistance had less
allelic diversity compared to blaOXA-61 and tetO (Fig. 2) and
showed evidence of gene pool transmission between bac-
terial species and isolate source populations. Three alleles
of the aad9, ant(6)-Ib, sat-4 genes were shared between
C. jejuni and C. coli isolates. The ant(6)-Ib allele was found
in C. jejuni isolates from humans, cattle, chickens and in
C. coli isolates from humans, chickens and sewage. The
aad9 allele was found in human C. jejuni isolates and in
C. coli isolates from humans, chickens, pigs and sewage.
The sat-4 allele was found in C. jejuni isolates from cattle
and chicken and in C. coli isolates from human, chicken
and sewage sources (Fig. 5). Alleles of other genes associ-
ated with aminoglycoside resistance (ant-like A, aad9, ant
(6)-Ib, aph(3)-IIIa, hpt and aph(2)-IIIa) also showed evi-
dence of transfer (allele sharing) between isolates sampled
from different sources (Fig. 5).
Discussion
Forecasts of rising AMR in bacteria can make dramatic
claims, such as an associated death toll of 10 million
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per locus. The left y-axis indicates the number of core genes (black
line), the right y-axis indicates the number of AMR genes (blue line).
For the consistency index, the two distributions were significantly dif-
ferent (two-tailed Mann–Whitney test; p = 0.0214, Mann–Whitney
U = 3307). For the number of alleles per locus, the two distributions
were significantly different (two-tailed Mann–Whitney test; p < 0.0001,
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people by 2050 if no action is taken (Balouiri et al.,
2016). However, for priority pathogens such as Campylo-
bacter (WHO, 2017) it is not always clear where such
action should be targeted. One reason for this is that zoo-
notic bacteria do not reside in a single host niche, there-
fore the source and sink dynamics of resistant strains may
be poorly understood. Furthermore, the conduit for trans-
mission between niches (in this case faeces) may also
represent a reservoir of AMR. Here, by focussing analyses
on comparison of gene pools, rather than individual resis-
tant clones, we directly address if the alleles that confer
resistance have spread between pathogenic Campylobac-
ter species and the niches in which they reside.
Human infection is often a dead-end for Campylobacter
as disease is usually self-limiting and human-to-human
transmission is uncommon. As antibiotic treatment for
campylobacteriosis is generally only given in acute or per-
sistent cases, the heavy use of related antimicrobials in
human and veterinary medicine (Schwarz et al., 2001;
Teuber, 2001; Livermore, 2007) has raised concerns
about how selection for resistance in livestock may lead
to AMR in human pathogens. Despite the ban on the use
of antibiotics as growth promoters in animals in 2006,
quinolones and tetracyclines are still available for treat-
ment of livestock all over the world (WHO, 2017). Consis-
tent with trends in a recent ECDC report (Food and
Authority, 2019), resistance to ciprofloxacin and tetracy-
cline was seen in both Campylobacter species in our
study, with resistance to streptomycin and gentamicin
also frequent among sequenced C. coli isolates
(Table 1). This may not be surprising as Spain has the
highest sale of aminoglycosides for veterinary use in the
EU (European Medicines Agency, 2018). Perhaps
equally worrying was the isolation of C. coli resistant to
erythromycin which is the drug of choice for antibiotic
treatment of clinical campylobacteriosis (Acheson and
Allos, 2001). The extent to which this level of resistance
is a legacy of past use of fluoroquinolones, tetracyclines
(Toth et al., 2013; Cameron and Gaynor, 2014) and other
antimicrobials is not known but it is clear that
Allele 1
Allele 2
Allele 3
Allele 4
Allele 5
tetO
Allele 6
0
1
2
3
4
5
0
1
2
3
4
5
0
1
2
3
4
5
0
1
2
3
4
50
1
2
3
4
5
0
1
2
3
4
5
0
1
2
3
4
5
0
1
2
3
4
5
0
1
2
3
4
5
2
3
4
5
2
3
4
5
2
3
4
5
2
3
4
5
234
5
2
3
4
5
2
3
4
5
2
3
4
5
2
3
4
5
1
1
1
1
1
1
1
1
1
C. jejuni
C. coli
Allele 1
Allele 2
Allele 3
Allele 4
Allele 5
blaOXA-61
Chicken (n=7)
C
attle (n=1)
P
ig
 (
n=
3)
Hu
ma
n (
n=
34
)
Sewage (n=47)
Chicken (n=18)
C
attle (n=
26)
H
um
an
 (n
=1
8)
Sew
age 
(n=5
)
C. jejuni
C. coli
β-lactams
0
1
2
3
4
5
6
0
1
2
3
4
5
6
0
1
2
3
4
5
6
0
1
2
3
4
5
6
0
1
2
34
5
6
0
1
2
3
4
5
6
0
1
2
3
4
5
6
0
1
2
3
4
5
6
0
1
2
3
4
5 6
2
3
4
5
6
2
3
4
5
6
2
3
4
5
6
2
3
4
5
6
2345
6
2
3
4
5
6
2
3
4
5
6
2
3
4
5
6
2
3
4
5 6 1
1
1
1
1
1
1
1
1
Tetracyclines
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10
110
1
2
3
45
67
8
910
11
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10 11
2.1 2.2 2.3 3.1 3.2
2.1
2.2
2.3
3.1
3.2
2.1
2.
2
2.
3
3.
1
3.
2
2.
1
2.
2
2.
3
3.1
3.2
2.12.22.33.13.2
2.1
2.2
2.3
3.1
3.2
2.1
2.2
2.3
3.1
3.2
2.
1
2.
2
2.
3
3.
1
3.
2
2.1
2.2
2.3
3.1
3.2
4
5
6
7
8
4
5
6
7
8
4
5
6
7
8
4
5
6
7
8
456
78
4
5
6
7
8
4
5
6
7
8
4
5
6
7
8
4 5
6 7 8 1
1
1
1
1
1
1
1
1
Allele 1
2.1 Allele 1
2.2 Allele 2
2.3 Allele 3
3.1 Allele 1
1. ant-like B
2. ant-like A
3. aad9
3.2 Allele 2
5. sat-4
Allele 1
6. aph(3)-IIIa
Allele 1
Allele 1
4. ant(6)-Ib
7. hpt
Allele 1
8. aph(2)-IIIa
Allele 1
C. jejuni
C. coli
4
Aminoglycosides
Chicken (n=7)
C
attle (n=1)
P
ig
 (
n=
3)
Hu
ma
n (
n=
34
)
Sewage (n=47)
Chicken (n=18)
C
attle (n=
26)
H
um
an
 (n
=1
8)
Sew
age 
(n=5
)
Chicken (n=7)
C
attle (n=1)
P
ig
 (
n=
3)
Hu
ma
n (
n=
34
)
Sewage (n=47)
Chicken (n=18)
C
attle (n=
26)
H
um
an
 (n
=1
8)
Sew
age 
(n=5
)
Fig. 5. Distribution of AMR gene alleles among Campylobacter species and isolate source. Circus plots indicate the number of C. jejuni and
C. coli isolates sampled from chickens (dark green), cattle (green), pigs (light green), humans (red) and sewage (blue) that contain genes associ-
ated with resistance to β-lactam, tetracycline and aminoglycoside antimicrobials. Alleles present in > 5 isolate genomes are numbered around the
perimeter. Exact matches between allele sequences are indicated by joining lines, coloured differently for different alleles. [Color figure can be
viewed at wileyonlinelibrary.com]
© 2019 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.,
Environmental Microbiology, 21, 4597–4613
4606 E. Mourkas et al.
Campylobacter harbour numerous resistance genes,
potentially exacerbated by the carriage of similar genes
among other components of the microbiota (van den
Bogaard, 2000; Holmes et al., 2016).
AMR is widespread among Campylobacter isolated
from livestock (Qin et al., 2014; Wang et al., 2014;
Florez-Cuadrado et al., 2016; Sproston et al., 2018), but
the transmission dynamics are poorly understood. Where
resistance is conferred by a single (or few) nucleotide
substitution(s), such as in the gyrA gene (fluoroquinolone
resistance; Engberg et al., 2001; Payot et al., 2006; Zhao
et al., 2016), it is impossible to tell from sequence data if
HGT or point mutation were responsible. For other clas-
ses of antibiotics, for example tetracyclines, there is evi-
dence for the transfer of genes (e.g., tetO) between
C. jejuni isolates, even in the absence antimicrobial
selective pressure (Qin et al., 2012). In addition to tetO,
our analyses identified 14 other accessory genes associ-
ated with Campylobacter resistance to other known anti-
microbial classes (Supporting Information Table S4).
These included aminoglycosides (10 genes), β-lactams
(blaOXA-61) and macrolides (ermB) that have been vari-
ously used as treatments targeting Campylobacter and
other infectious agents (or even as growth promoters;
Engberg et al., 2001) in humans and animals (Lambert
et al., 1985; Engberg et al., 2001; Griggs et al., 2009; Qin
et al., 2012, 2014; Chen et al., 2013; Toth et al., 2013;
Florez-Cuadrado et al., 2016, 2017; Lapierre et al., 2016;
Yao et al., 2017). Initial evidence of the importance of
HGT in the transmission of these genes can be seen with
inconsistent topology of individual AMR gene trees, com-
pared to the Campylobacter core genome phylogeny
(Supporting Information Fig. S1). Specifically, the CI var-
ied for the 11 AMR genes, highlighting a disparity in the
amount of inferred homoplasy in these genes, compared
to genes in the core genome (Fig. 4B). Furthermore, the
allelic variation in the AMR-associated genes was signifi-
cantly lower than the mean for core genes. Convergent
genotypes may have evolved multiple times in different
genetic backgrounds, however the most parsimonious
explanation is the spread of AMR via HGT.
Perhaps the most compelling evidence for HGT is the
identification of co-localized clusters of genes that consti-
tute GIs. Consistent with evidence of aminoglycoside
resistance in Campylobacter (Lambert et al., 1985;
Gibreel et al., 2004; Qin et al., 2012; Lapierre et al.,
2016), all AMR genes detected in our study were found
in MDR GIs, except for blaOXA-61, ant-like A and ant-like
B. There were multiple syntenic arrangements of genes
with some GIs containing genes that confer resistance to
more than one antimicrobial drug class (macrolides and
aminoglycosides) as previously reported (Werner et al.,
2003). Some of the MDR GIs are known from previous
studies (ant(6)-Ia, sat-4 and aph(3)-IIIa; Derbise et al.,
1996, 1997), while others are reported here for the first
time, such as the association between TetO, aad9 and
ant(6)-Ib genes. GI similarities provide evidence of trans-
fer between C. jejuni and C. coli, and gene pool transmis-
sion among isolates from animals, humans and sewage.
The transfer of GIs in Campylobacter can be via natural
transformation (Qin et al., 2012), however several GIs
were found on plasmids or integrative conjugative ele-
ments (Fig. 3) indicating the active mobilization of gene
clusters. GIs containing the ant(6)-Ia, sat-4 and aph(3)-
IIIa cluster, and the tetO gene, have previously been
described in staphylococci (Lambert et al., 1985; Derbise
et al., 1996, 1997). Furthermore, the conjugative transpo-
son found in C. coli was highly similar (~99.4% nucleo-
tide identity over at least 60% of the sequence) to related
sequence in other Gram-positive bacteria. This is consis-
tent with the circulation of AMR genes not only among
Campylobacter species in different habitats but also
HGT from other bacteria (Trieu-Cuot et al., 1985; Zilhao
et al., 1988).
An important finding in our study was that C. coli carry
more combinations of AMR genes simultaneously than
C. jejuni (Table 2). A simple explanation could be that
C. coli ST-828 complex isolates are more recom-
binogenic. There is evidence of the accumulation of
C. jejuni DNA throughout the genome of this lineage
(Sheppard et al., 2008, 2013) which could have led to the
acquisition of multiple AMR genes. It is also possible that
the dominance of this C. coli lineage (ST-828 complex),
that is much less diverse than C. jejuni as a whole, reflects
a genetic bottleneck that favoured an ancestral AMR strain
in, for example, the pig gut where C. coli (Thakur et al.,
2006) and antimicrobial exposure (Aarestrup et al., 2000)
are common. Whatever the reasons for differences in
MDR between C. jejuni and C. coli, there is clear evi-
dence for HGT and the transmission of AMR genes
among bacterial species and host niche gene pools.
Contrasting evidence of HGT with quantitative informa-
tion about the transmission of resistant bacteria between
hosts would be extremely useful for understanding the
dissemination of AMR among isolates from different habi-
tats. In Campylobacter, studies have attempted to esti-
mate the number of strains excreted into the environment
by different animals (Ogden et al., 2009) and attribute the
source of human infection to livestock (especially poultry)
reservoirs (Sheppard et al., 2009b; Thépault et al., 2017,
2018). However, these large-scale probabilistic studies
are utterly underpowered for investigating the almost infi-
nite number of possible transmission events, where the
survival and proliferation of a single strain in a new niche
could lead to the transfer of AMR genes between hosts
and environments. A theoretical solution to the spread of
AMR could be to use different drug classes in animals on
the assumption that distinct antimicrobial selection
© 2019 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.,
Environmental Microbiology, 21, 4597–4613
Gene pool transmission of AMR 4607
pressures would sustain efficacy of drugs in humans.
However, even if this was feasible, evidence from this
study (and others (Hendriksen et al., 2019)) shows that
multidrug resistant bacteria can be isolated and cultured
from sewage, presenting a potential route for transmis-
sion of AMR in the environment. While the sources and
implications of environmental contamination remain con-
troversial (Rizzo et al., 2013; Munck et al., 2015), the evi-
dence in our study is consistent with the horizontal
transfer of AMR among Campylobacter isolated from
livestock, humans and sewage. This suggests that judi-
cious use of antimicrobials and monitoring of the amount
of AMR Campylobacter entering the environment may be
beneficial in combating the rise of resistance in this
important zoonotic pathogen.
Experimental procedures
Culture and antimicrobial susceptibility testing
As part of routine Campylobacter surveillance in Spain,
isolates were sampled and cultured on blood agar plates
(bioMérieux) and incubated for 48 h at 37C under micro-
aerophilic conditions using Campygen atmosphere genera-
tion system packs (Oxoid, Basingstoke, U.K.). Subcultured
colonies were harvested and suspended in sterile water to a
standardized cell density (0.5 McFarland turbidity). Fifty
microliters of this suspension was added to 11 ml of Mueller-
Hinton broth (TREK Diagnostics Systems, Waltham, MA)
supplementedwith 5.5% lysed horse blood (Oxoid). The solu-
tion was poured onto EUCAMP2 microdilution plates (TREK
Diagnostics Systems) which were incubated under micro-
aerophilic conditions for 48 h at 37C as previously described
(Florez-Cuadrado et al., 2017). The interpretation of the quan-
titative data was performed according to the European Com-
mittee of Antimicrobial Susceptibility Testing, EUCAST (http://
www.eucast.org/; last accessed: 06/2017).
DNA extraction, genome sequencing and archiving
A total of 260 Campylobacter isolates (167 C. jejuni and
92 C. coli) that displayed MDR phenotypes were chosen
for genome sequencing. These represented strains sampled
from humans, livestock and urban effluents in Spain. Of
these, 55 isolates originated in animals (44 C. jejuni and
11 C. coli) including broiler chickens (18 C. jejuni and
7C. coli), cattle (26C. jejuni and 1C. coli) and pigs (3C. coli)
and were collected from abattoirs in Spain (2008–2011) as
part of the Spanish Veterinary Antimicrobial Resistance Sur-
veillance (VAV) Network (Supporting Information Table S1).
The isolates were chosen on the basis of resistance profiles
(susceptible to resistant) to five different antibiotics
(Table 1). Human samples (n = 152; 118 C. jejuni and
34 C. coli) were associated with campylobacteriosis cases
in hospitals in the regions of Castilla y Leon, Extremadura
and Andalucía between 2013 and 2016. Campylobacter
isolates of urban effluent origin (n = 53; 6 C. jejuni and
47 C. coli) were collected from the wastewater treatment
plants in the city of Madrid (Spain) between 2011 and 2013
(Ugarte-Ruiz et al., 2015). All isolates were obtained using
culture based methods (Moreno et al., 2000; Ugarte-Ruiz
et al., 2015; Hormeño et al., 2016) and speciated as
C. jejuni or C. coli using a conventional multiplex PCR as
previously described (Ugarte-Ruiz et al., 2012).
For genome sequencing, isolates stored at −80C in
1% protease peptone and 10% glycerol broth were cul-
tured onto blood agar plates (bioMérieux) in micro-
aerophilic conditions at 42C for 48 h as previously
described (Florez-Cuadrado et al., 2017). Genomic DNA
was extracted using the QIAamp DNA Mini Kit (QIAGEN,
Crawley, U.K.), according to manufacturer’s instructions.
Nucleic acid content was quantified on a Nanodrop spec-
trophotometer prior to normalization and sequencing.
Libraries were prepared with Nextera XT kits (v2) and
high-throughput sequencing was performed using an
Illumina MiSeq sequencer (Illumina, San Diego, CA; v3
technology, 300 bp paired-end). Short reads were assem-
bled de novo using SPAdes (version 3.8.0). All genomes
used in this study were archived on the BIGSdb web-
based database platform (Jolley and Maiden, 2010) and
given a unique identification number (BIGSid; Supporting
Information Table S1).
Phylogenetic analysis
A pangenome was created for all isolate genomes in our
collection as the sum of core genes, shared by all iso-
lates, and accessory genes, present in at least one iso-
late. Genomes with a total assembly length > 1.9 Mbp,
> 500 contigs or an N95 < 800 bp were considered poor
quality and were excluded from the phylogenetic ana-
lyses. Whole genome multiple sequence alignments
were obtained using MAFFT (Katoh, 2002) following a
gene-by-gene approach as previously described (Méric
et al., 2014). Phylogenetic trees, based on gene-by-
gene alignments of core genes (Méric et al., 2014) or
single gene sequences, were reconstructed using the
Neighbour joining clustering method (Saitou and
Nei, 1987).
Screening for AMR genes
AMR genes were identified in all Campylobacter genomes
by comparison with the CARD (Jia et al., 2017; last
assessed: 03/06/2017), the ResFinder (Zankari et al., 2012)
and the NCBI databases using the BLAST algorithm
(Sheppard et al., 2012; Maiden et al., 2013). A locus match
was defined when genes had > 70% nucleotide identity
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over > 50% of the sequence length, and a matrix was gen-
erated that contained presence/absence information for
each card gene and the allelic variation at that locus for
every genome. Following the identification of isolate
genomes harbouring one or more AMR genes, contigs
were screened for upstream and downstream open reading
frames (ORFs) to characterize the location of AMR relative
to adjacent genes, using SnapGene software (GSL Biotech;
available at snapgene.com). A second confirmatory analy-
sis was performed, in which contigs were compared to
NCBI database to identify whether they are associated with
known plasmid or mobile elements. Sequence matches
with > 95% nucleotide identity over > 50% of the sequence
length were considered positive hits. A bivariate analysis
was performed, in Stata version 14.0 (StataCorp, College
Station, TX), to determine the relationship between pheno-
types and genotypes for the presence of resistance using
the Fisher’s exact test. Associations were considered signif-
icant when p < 0.05.
HGT among infection-associated genes
Population genetic analyses were undertaken to compare
molecular variation among AMR genes to investigate pat-
terns of HGT between species and isolates sampled form
different niches. Genes where AMR is mediated by single
nucleotide polymorphisms (SNPs), for example gyrA in
fluroquinolone resistance (Sproston et al., 2018), were
excluded from this analysis because of the inability to distin-
guish de novo mutation from homologous recombination of
similar sequence. The allelic variation was calculated at loci
associated with AMR genes (n = 15) and compared to vari-
ation at core loci (n = 595 genes). For both groups, the
number of alleles at each locus (determined using a whole-
genome multilocus sequence typing, MLST, approach
(Sheppard et al., 2012) and CI) were calculated. The con-
sistency of a phylogenetic tree to patterns of variation in
sequence alignments was determined for each gene of
interest, and constituted an inference of the minimum
amount of homoplasy in these genes, as implied by the
tree (Kluge and Farris, 1969). The CI function from the R
Phangorn package (Schliep, 2011) was used to calculate
consistency indices for every single-gene alignment of the
15 AMR genes to a phylogeny constructed from a
concatenated gene-by-gene alignment of 595 core genes
shared by all 259 isolates. The average CI of these shared
genes was compared to that of the AMR genes.
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Fig. S1. Individual AMR gene trees. 14 single-gene trees
highlighting the allelic diversity in AMR genes found in C.
jejuni (grey) and C.coli (black) isolates shown in the first
column. The resistance status of each isolate is
highlighted in the second column for multidrug resistant
(dark pink), non-multidrug resistance (light pink) or not
tested (white). The host of every isolate is shown in the
third column for chickens (dark green), cattle (green),
pigs (light green), humans (red) and sewage (blue). The
scale bars represent the number of substitutions per site.
Fig. S2. Prevalence of AMR genes over time. Graphs
illustrate the presence of 15 putative AMR genes in iso-
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lence (%) was calculated by dividing the number of
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samples in that year.
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